SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Elizabeth Barrett Browning Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientElizabeth Barrett Browning
Date of birth1806-03-06
IdentifiersMRN HR-NI026-SYN-TD; SSN (made up) 000-26-4157
Document date2026-11-01
AuthorClementine Haverford-Asante, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New patient visit for chronic cough with blood-streaked sputum, a long-term opioid prescription, and grief, with tuberculosis testing and urgent pulmonology referral. Concerns: She has coughed for years and lately sees streaks of blood; she wants to know whether it is consumption; She worries that the morphine she has taken for so long is harming her, but fears being made to stop it; She wants to keep writing, and to be able to think of her brother without being overwhelmed. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Morphine sulfate 2 mg/mL oral solution, 5 mL (10 mg) by mouth twice daily, morning and bedtime (20 mg a day; long-standing prescription, continued)5 mL (10 mg) twice daily, morning and bedtimeOral route1838-03-01 to 1845-04-19completedS
Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeat in 2 to 3 minutes in the other nostril if no response; call 911As needed for suspected overdose; keep two devices at homeNasal route1845-03-16activeS
Cholecalciferol (vitamin D3) 1000 unit (25 mcg) oral tablet, two tablets (1819 units) by mouth dailyTwo tablets dailyOral route1845-03-16activeS
Amoxicillin 500 mg oral capsule, one capsule by mouth three times daily for 14 daysOne capsule three times daily for 14 daysOral route1845-08-10 to 1845-08-23completedS
Morphine sulfate 2 mg/mL oral solution, 4.5 mL (9 mg) by mouth twice daily, morning and bedtime (18 mg a day)4.5 mL (9 mg) twice daily, morning and bedtimeOral route1845-04-20 to 1845-06-14completedS
Morphine sulfate 2 mg/mL oral solution, 4 mL (8 mg) by mouth twice daily, morning and bedtime (16 mg a day)4 mL (8 mg) twice daily, morning and bedtimeOral route1845-06-15 to 1845-10-18completedS
Morphine sulfate 2 mg/mL oral solution, 3.5 mL (7 mg) by mouth twice daily, morning and bedtime (14 mg a day)3.5 mL (7 mg) twice daily, morning and bedtimeOral route1845-10-19activeS

Procedures

ProcedureDatesStatusEvidence
CT of the chest with intravenous contrast and thin-section reconstructions1845-03-23 to 1845-03-23completedS
Spirometry before and after bronchodilator1845-03-23 to 1845-03-23completedS
Bone density scan (DXA) of the lumbar spine and hip1845-04-20 to 1845-04-20completedS
Advance care planning conversation, about 20 minutes1845-07-13 to 1845-07-13completedS

Immunizations

DateVaccineStatusEvidence
1845-07-13Tetanus, diphtheria, and acellular pertussis vaccine (Tdap)completedS
1845-07-13Pneumococcal conjugate vaccine, 20-valent (PCV20)completedS
1845-07-13Hepatitis B vaccine (HepB-CpG), dose 1 of 2completedS
1845-10-19Hepatitis B vaccine (HepB-CpG), dose 2 of 2completedS
1845-10-19Influenza vaccine, inactivated, this seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1821Serious illness at about fifteen, from which she nearly died, treated at a spa for most of a year; a spinal injury, later attributed to a strain, contributed to lasting weakness; a prescribed opiate from then onD (CLM-0002, CLM-0003, CLM-0004)
1838Chest illness with blood in the sputum (described as a broken blood vessel), judged by her physicians to be an affection of the lungs but not tubercular consumption; largely confined indoors sinceD (CLM-0005, CLM-0011)
1840Severe decline in health after the drowning of her brother, with slow recovery over the following winterD (CLM-0007, CLM-0008)

Family History

RelativeConditionAge at deathEvidence
motherDied after a last illness when the patient was in her early twenties; cause not recorded in the cited sourceD (CLM-0010)
brotherDied by accidental drowning in a sailing accident five years agoD (CLM-0007)
brotherDied abroad earlier in the same year; cause not recorded in the cited sourceD (CLM-0009)

Health Concerns

ConcernStatusEvidence
She has coughed for years and lately sees streaks of blood; she wants to know whether it is consumptionactiveS
She worries that the morphine she has taken for so long is harming her, but fears being made to stop itactiveS
She wants to keep writing, and to be able to think of her brother without being overwhelmedactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 12.3 on 1845-03-16; MCV [Entitic mean volume] in Red Blood Cells by Automated count 88 on 1845-03-16; Leukocytes [#/volume] in Blood by Automated count 11.8 on 1845-08-10; Eosinophils [#/volume] in Blood 0.21 on 1845-03-16; Platelets [#/volume] in Blood by Automated count 352 on 1845-03-16; C reactive protein [Mass/volume] in Serum or Plasma 38 on 1845-08-10; Sodium [Moles/volume] in Serum or Plasma 139 on 1845-03-16; Potassium [Moles/volume] in Serum or Plasma 4.1 on 1845-03-16; Creatinine [Mass/volume] in Serum or Plasma 0.66 on 1845-03-16; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1840)/1.73 sq M 114 on 1845-03-16; Glucose [Mass/volume] in Serum or Plasma 84 on 1845-03-16; Calcium [Mass/volume] in Serum or Plasma 9.2 on 1845-03-16; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 34 on 1845-06-15; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 on 1845-10-19; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 5 on 1845-06-15; FEV1 --post bronchodilation 2.02 on 1845-03-23; FEV1 measured/predicted 74 on 1845-03-23; Forced vital capacity [Volume] Respiratory system --post bronchodilation 2.93 on 1845-03-23; FEV1/FVC --post bronchodilation 0.69 on 1845-03-23; IgG [Mass/volume] in Serum or Plasma 1180 on 1845-03-23; IgA [Mass/volume] in Serum or Plasma 236 on 1845-03-23; IgM [Mass/volume] in Serum or Plasma 142 on 1845-03-23; IgE [Units/volume] in Serum or Plasma 38 on 1845-03-23; Aspergillus fumigatus IgE Ab [Units/volume] in Serum 0.08 on 1845-03-23; DXA Lumbar spine [Z-score] Bone density -1.4 on 1845-04-20; DXA Femur [Z-score] Bone density -1.1 on 1845-04-20; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 1845-07-13; Total score [AUDIT-C] 0 on 1845-07-13 [S]

Strengths and supports: Supports: her writing, her correspondents, her sisters' company, and a strong sense of humour; financially independent through a legacy [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic cough with daily yellow sputum, occasional streaks of blood, and breathlessness on stairs, worse in winter, for several years after an illness with blood in the sputum about eight years ago; tuberculosis, nontuberculous mycobacteria and bronchiectasis to be distinguishedresolvedconfirmed R05.3S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the consultation; it echoes her documented chest illness (D).
Non-cystic fibrosis bronchiectasis of the left lower lobe and lingula with chronic Haemophilus influenzae infection and mild airflow obstruction (Bronchiectasis Severity Index 3, mild); tuberculosis and nontuberculous mycobacterial disease excluded; synthetic modern diagnosis chosen for a historical chest illness whose cause is disputedactiveconfirmed J47.9S — Synthetic modern diagnosis; the nature of her historical chest illness remains undetermined (R, disputed).
Long-term prescribed opioid therapy (oral morphine 20 mg a day for many years, for cough, sleeplessness and palpitations), with expected physiological dependence; no opioid use disorder on DSM-5-TR assessmentactiveconfirmed Z79.891S — Synthetic modern problem anchored to her documented prescribed opium (D); tolerance and withdrawal on prescribed opioids do not count toward opioid use disorder.
Prolonged grief disorder after the drowning of her closest brother five years ago, with yearning, self-blame, avoidance of reminders of the sea, and depressive symptoms (PHQ-9 12); no suicidal ideationactiveconfirmed F43.81S — Synthetic modern diagnosis anchored to her documented bereavement (D); not a claim about her real mental health.
Vitamin D deficiency (25-hydroxyvitamin D 15 ng/mL) in a woman who rarely goes outdoorsresolvedconfirmed E55.9S — Synthetic finding at intake; repleted by twelve weeks.
Underweight (BMI 16.8) with a small appetiteactiveconfirmed R63.6S — Synthetic finding at intake.
Exacerbation of bronchiectasis (more sputum, purulent sputum, more cough and breathlessness for three days, with low-grade fever), treated with amoxicillin for 14 days and more frequent airway clearance; resolvedresolvedconfirmed J47.1S — Synthetic intercurrent exacerbation; not a historical claim.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1845-03-16Hemoglobin [Mass/volume] in Blood12.3g/dL12-15.5 g/dLNormalS
1845-03-16MCV [Entitic mean volume] in Red Blood Cells by Automated count88fL80-100 fLNormalS
1845-03-16Leukocytes [#/volume] in Blood by Automated count8.610*3/uL4-11 10*3/uLNormalS
1845-03-16Eosinophils [#/volume] in Blood0.2110*3/uL0-0.5 10*3/uLNormalS
1845-03-16Platelets [#/volume] in Blood by Automated count35210*3/uL150-400 10*3/uLNormalS
1845-03-16C reactive protein [Mass/volume] in Serum or Plasma8.4mg/L<=5 mg/LHighS
1845-03-16Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1845-03-16Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
1845-03-16Creatinine [Mass/volume] in Serum or Plasma0.66mg/dL0.57-1 mg/dLNormalS
1845-03-16Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1840)/1.73 sq M114mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1845-03-16Glucose [Mass/volume] in Serum or Plasma84mg/dL70-139 mg/dLNormalS
1845-03-16Calcium [Mass/volume] in Serum or Plasma9.2mg/dL8.6-10.3 mg/dLNormalS
1845-03-1625-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma15ng/mL30 to 100 ng/mL sufficient; below 20 ng/mL deficientLowS
1845-03-16Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]12{score}S
1845-03-16Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]9{score}S
1845-03-23FEV1 --post bronchodilation2.02LLower limit of normal for her age, sex and heightLowS
1845-03-23FEV1 measured/predicted74%>=80%LowS
1845-03-23Forced vital capacity [Volume] Respiratory system --post bronchodilation2.93LLower limit of normal for her age, sex and heightNormalS
1845-03-23FEV1/FVC --post bronchodilation0.69{ratio}Lower limit of normal for her age about 0.72LowS
1845-03-23IgG [Mass/volume] in Serum or Plasma1180mg/dL700-1600 mg/dLNormalS
1845-03-23IgA [Mass/volume] in Serum or Plasma236mg/dL70-400 mg/dLNormalS
1845-03-23IgM [Mass/volume] in Serum or Plasma142mg/dL40-230 mg/dLNormalS
1845-03-23IgE [Units/volume] in Serum or Plasma38[IU]/mL<=100 [IU]/mLNormalS
1845-03-23Aspergillus fumigatus IgE Ab [Units/volume] in Serum0.08k[IU]/LBelow 0.35 kU/L: negativeNormalS
1845-04-20DXA Lumbar spine [Z-score] Bone density-1.4{Z-score}Above -2.0 is within the expected range for ageNormalS
1845-04-20DXA Femur [Z-score] Bone density-1.1{Z-score}Above -2.0 is within the expected range for ageNormalS
1845-04-20C reactive protein [Mass/volume] in Serum or Plasma4.1mg/L<=5 mg/LNormalS
1845-04-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]10{score}S
1845-06-1525-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma34ng/mL30 to 100 ng/mL sufficient; below 20 ng/mL deficientNormalS
1845-06-15Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S
1845-06-15Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]5{score}S
1845-10-19C reactive protein [Mass/volume] in Serum or Plasma3.2mg/L<=5 mg/LNormalS
1845-10-19Leukocytes [#/volume] in Blood by Automated count7.410*3/uL4-11 10*3/uLNormalS
1845-10-19Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
1845-08-10C reactive protein [Mass/volume] in Serum or Plasma38mg/L<=5 mg/LHighS
1845-08-10Leukocytes [#/volume] in Blood by Automated count11.810*3/uL4-11 10*3/uLHighS
1845-07-13Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
1845-07-13Total score [AUDIT-C]0{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
1845-03-16Body height157cmS
1845-03-16Body weight41.5kgS
1845-03-16Body mass index (BMI) [Ratio]16.8kg/m2S
1845-03-16Systolic blood pressure102mm[Hg]S
1845-03-16Diastolic blood pressure64mm[Hg]S
1845-03-16Heart rate96/minS
1845-03-16Respiratory rate18/minS
1845-03-16Body temperature36.9CelS
1845-03-16Oxygen saturation in Arterial blood by Pulse oximetry96%S
1845-03-23Body height157cmS
1845-03-23Body weight41.6kgS
1845-03-23Body mass index (BMI) [Ratio]16.9kg/m2S
1845-03-23Systolic blood pressure100mm[Hg]S
1845-03-23Diastolic blood pressure64mm[Hg]S
1845-03-23Heart rate92/minS
1845-03-23Respiratory rate18/minS
1845-03-23Body temperature36.8CelS
1845-03-23Oxygen saturation in Arterial blood by Pulse oximetry96%S
1845-04-20Body height157cmS
1845-04-20Body weight42.4kgS
1845-04-20Body mass index (BMI) [Ratio]17.2kg/m2S
1845-04-20Systolic blood pressure104mm[Hg]S
1845-04-20Diastolic blood pressure66mm[Hg]S
1845-04-20Heart rate88/minS
1845-04-20Respiratory rate16/minS
1845-04-20Body temperature36.7CelS
1845-04-20Oxygen saturation in Arterial blood by Pulse oximetry97%S
1845-06-15Body height157cmS
1845-06-15Body weight43.3kgS
1845-06-15Body mass index (BMI) [Ratio]17.6kg/m2S
1845-06-15Systolic blood pressure106mm[Hg]S
1845-06-15Diastolic blood pressure66mm[Hg]S
1845-06-15Heart rate84/minS
1845-06-15Respiratory rate16/minS
1845-06-15Body temperature36.7CelS
1845-06-15Oxygen saturation in Arterial blood by Pulse oximetry97%S
1845-10-19Body height157cmS
1845-10-19Body weight44.2kgS
1845-10-19Body mass index (BMI) [Ratio]17.9kg/m2S
1845-10-19Systolic blood pressure106mm[Hg]S
1845-10-19Diastolic blood pressure68mm[Hg]S
1845-10-19Heart rate82/minS
1845-10-19Respiratory rate16/minS
1845-10-19Body temperature36.6CelS
1845-10-19Oxygen saturation in Arterial blood by Pulse oximetry97%S
1845-08-10Body height157cmS
1845-08-10Body weight43.4kgS
1845-08-10Body mass index (BMI) [Ratio]17.6kg/m2S
1845-08-10Systolic blood pressure104mm[Hg]S
1845-08-10Diastolic blood pressure64mm[Hg]S
1845-08-10Heart rate102/minS
1845-08-10Respiratory rate20/minS
1845-08-10Body temperature37.9CelS
1845-08-10Oxygen saturation in Arterial blood by Pulse oximetry95%S
1845-07-13Body height157cmS
1845-07-13Body weight43.8kgS
1845-07-13Body mass index (BMI) [Ratio]17.8kg/m2S
1845-07-13Systolic blood pressure106mm[Hg]S
1845-07-13Diastolic blood pressure66mm[Hg]S
1845-07-13Heart rate82/minS
1845-07-13Respiratory rate16/minS
1845-07-13Body temperature36.7CelS
1845-07-13Oxygen saturation in Arterial blood by Pulse oximetry97%S

Encounters

DatePurposeStatusProvenance
1845-03-16New patient visit for chronic cough with blood-streaked sputum, a long-term opioid prescription, and grief, with tuberculosis testing and urgent pulmonology referralfinishedS
1845-03-23Pulmonology consultation with CT of the chest and spirometry, diagnosis of bronchiectasis, and the start of airway clearancefinishedS
1845-04-20Four-week review: mycobacterial cultures, airway clearance, bone density, grief therapy, and her choice about the opioid dosefinishedS
1845-06-15Three-month review: final mycobacterial cultures, vitamin D, mood, safety, and the opioid dosefinishedS
1845-10-19Seven-month review after an exacerbation: lungs, opioid therapy, mood, safety, weight, and vaccinesfinishedS
1845-08-10Same-day sick visit for an exacerbation of bronchiectasisfinishedS
1845-07-13Periodic adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Evaluation of chronic cough with blood-streaked sputum: three sputum samples at least eight hours apart, one early morning, for acid-fast smear, nucleic acid amplification and mycobacterial culture (including nontuberculous mycobacteria) and routine bacterial culture; interferon-gamma release assay and HIV test; blood count, CRP and metabolic panel; CT of the chest within a week; a mask in shared spaces until the smears are negative; call 911 or go to the emergency department for more than a few teaspoons of blood, blood with breathlessness, or chest paincompletedGL-ATS-TB-2017, GL-NTM-2020, GL-BTS-BE-2019S
Urgent pulmonology consultation within one week for chronic productive cough with blood-streaked sputum: exclude tuberculosis, confirm or exclude bronchiectasis and plan its care, and advise on opioids and the lungscompletedGL-BTS-BE-2019, GL-ATS-TB-2017S
Long-term opioid therapy review: prescription monitoring program checked (one prescriber, one pharmacy), urine drug test consistent with morphine only, naloxone prescribed and taught, no benzodiazepines or other sedatives, DSM-5-TR assessment (no opioid use disorder), dose continued unchanged with no forced taper, benefits and harms reviewed at every visit and at least every three months, the monitoring program checked with every prescription, and buprenorphine offered if opioid use disorder ever developscompletedGL-CDC-OPIOID-2022, GL-DSM5TR-2022S
Prolonged grief disorder therapy with the clinic psychologist, weekly for sixteen sessions, by video at first so she need not travel; PHQ-9 at every visitcompletedGL-PGD-2016, GL-DSM5TR-2022, GL-CMID-2026S
Collaborative safety plan with warning signs, coping steps, people to contact, the clinic number and the 988 Suicide & Crisis Lifeline; morphine kept in a locked box with only the current bottle out; safety reviewed at every visitcompletedGL-SUICIDE-2024, GL-CDC-OPIOID-2022S
Bone and nutrition: vitamin D3 1819 units daily with a recheck at twelve weeks; DXA for low weight, vitamin D deficiency, limited weight-bearing and long-term opioid therapy; calcium-rich foods, small frequent meals and an oral supplement drink with the clinic dietitian; weight at every visitcompletedGL-CMID-2026S
Bronchiectasis care: active cycle of breathing with an oscillating positive expiratory pressure device twice daily, taught by the respiratory physiotherapist; a home exercise program; influenza, pneumococcal and COVID-19 vaccines; a written exacerbation plan with a sputum sample and amoxicillin 500 mg three times daily for 14 days; sputum culture at each review and spirometry, Bronchiectasis Severity Index and mycobacterial culture yearly; no long-term macrolide while exacerbations are fewer than three a yearcompletedGL-BTS-BE-2019, GL-ERS-BE-2017S
Opioid dose reduction at her request: morphine lowered by about 10 percent at a time (to 18 mg a day now), with each step held at least four weeks, paused at any time she wishes, and never forced; withdrawal symptoms and sleep reviewed at each visitcompletedGL-CDC-OPIOID-2022S
Exacerbation of bronchiectasis: sputum culture before the first dose; amoxicillin 500 mg three times daily for 14 days; airway clearance three to four times a day; fluids; the morphine dose unchanged and no added cough suppressant; nurse phone check in two days; call 911 for more than a few teaspoons of blood, worsening breathlessness or confusioncompletedGL-BTS-BE-2019, GL-CDC-OPIOID-2022S

Goals

GoalTargetStatusOutcomeProvenance
Tuberculosis excluded and a diagnosis for the cough within two weeks1845-03-23completedSmears, NAAT and IGRA negative within a week; bronchiectasis diagnosed by CT at one weekS
Airway clearance twice daily, with less sputum and no blood in it, by three months1845-06-15completedAirway clearance twice daily; sputum down from about four to one tablespoon a day; no blood since the first monthS
Safe opioid therapy: naloxone at home, no overdose or sedation, and any dose change only by her choice1845-10-19completedNaloxone at home; no sedation; she chose to reduce from 20 to 14 mg a day over seven months without troublesome withdrawalS
Response of grief and depressive symptoms (PHQ-9 down by at least half) by six months1845-10-19completedPHQ-9 5 from 12 after sixteen sessions of grief therapy; she can speak of her brotherS
Weight up toward a BMI of 18.5 (45.6 kg) by seven months1845-10-19active44.2 kg from 41.5 kg (BMI 17.9); still gainingS
Vitamin D above 30 ng/mL by twelve weeks1845-06-15completed34 ng/mLS

Functional Status

Mental Status

Structured synthetic safety assessment on 1845-03-16: current ideation absent, intent absent, plan absent. Outpatient care with a collaborative safety plan, the 988 Suicide & Crisis Lifeline, her morphine kept in a locked box with only the current bottle out, naloxone at home, and review at every visit [S]